GlassScriptPhysician profile
Deangela Mcgee
NPI 1609558964
$1,389.18
in general payments reported to CMS, 2019-2025
11 companies · $1,389 in 2025
The $1,389 reported for 2025 was more than what 91% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,389.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $341.91 | 2025 | Opzelura, Opzelura |
| Galderma Laboratories, L.P. | $299.55 | 2025 | Nemluvio, Aklief |
| Novartis Pharmaceuticals Corporation | $233.67 | 2025 | |
| Leo Pharma INC. | $177.36 | 2025 | Anzupgo, Adbry |
| Abbvie INC. | $138.10 | 2025 | |
| Pfizer INC. | $49.44 | 2025 | |
| Ucb, INC. | $41.36 | 2025 | Bimzelx |
| Organon LLC | $36.24 | 2025 | Vtama |
| Sun Pharmaceutical Industries INC. | $30.82 | 2025 | |
| Arcutis Biotherapeutics, INC. | $22.34 | 2025 | Zoryve |
| E.R. Squibb & Sons, L.L.C. | $18.39 | 2025 | Sotyktu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deangela Mcgee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.